Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has informed the stock exchanges that its trading window will remain closed from July 1, 2025, until 48 hours after the company declares its financial results for the quarter ended June 30, 2025 (Q1 FY26). This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, insiders, directors, and designated employees are prohibited from trading in the company's shares. The window will reopen automatically once results are announced and a 48-hour cooling period lapses.
No direct impact on shareholders or stock price. This is a standard regulatory filing made ahead of quarterly results to ensure fair trading practices. Investors should watch for the upcoming Q1 FY26 results announcement, which will be the next material catalyst for the stock.